Effect of quercetin and its metabolite on caveolin-1 expression induced by oxidized LDL and lysophosphatidylcholine in endothelial cells

Journal of Clinical Biochemistry and Nutrition

Volumn 58, Issue 3, 2016, Pages 193-201

  Kamada, Chiemi ^a,b   Mukai, Rie ^a   Kondo, Akari ^a   Sato, Shinya ^a   Terao, Junji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b SHIKOKU UNIVERSITY   (Japan)

Author keywords

Adhesion molecule; Caveolin 1; Quercetin; Quercetin metabolite; Vascular endothelial cell

Indexed keywords

CAVEOLIN 1; CELL ADHESION MOLECULE; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; QUERCETIN;

ARTICLE; CAVEOLA; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STRUCTURE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

EID: 84968623970     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.16-2     Document Type: Article

References (55)

1. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-1011.
2. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995;155:381-386.
3. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996;156:637-642.
4. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 2000;130:2243-2250.
5. Chirumbolo S. Role of quercetin in vascular physiology. Can J Physiol Pharmacol 2012;90:1652-1657.
6. Terao J, Kawai Y, Murota K. Vegetable flavonoids and cardiovascular disease. Asia Pac J Clin Nutr 2008;17 Suppl 1:291-293.
7. Kamada C, da Silva EL, Ohnishi-Kameyama M, Moon JH, Terao J. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res 2005;39:185-194.
8. Kawai Y, Nishikawa T, Shiba Y, et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the antiatherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008;283:9424-9434.
9. Ishisaka A, Kawabata K, Miki S, et al. Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS One 2013;8:e80843.
10. Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP, Calò LA. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm 2013;2013:714653.
11. Frostegård J, Haegerstrand A, Gidlund M, Nilsson J. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 1991;90:119-126.
12. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109(23 Suppl 1):III27-32.
13. Fernández-Hernando C, Yu J, Dávalos A, Prendergast J, Sessa WC. Endothelial-specific overexpression of caveolin-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2010;177:998-1003.
14. Frank PG, Pavlides S, Lisanti MP. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res 2009;335:41-47.
15. Fernández-Hernando C, Yu J, Suárez Y, et al. Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab 2009;10:48-54.
16. Pavlides S, Gutierrez-Pajares JL, Iturrieta J, Lisanti MP, Frank PG. Endothelial caveolin-1 plays a major role in the development of atherosclerosis. Cell Tissue Res 2014;356:147-157.
17. Mukai R, Nakao R, Yamamoto H, Nikawa T, Takeda E, Terao J. Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tail-suspension mice. J Nat Prod 2010;73:1708-1710.
18. Khaidakov M, Wang X, Mehta JL. Potential involvement of LOX-1 in functional consequences of endothelial senescence. PLoS One 2011;6:e20964.
19. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008;3:1101-1108.
20. Nakamura T, Noma A, Shimada S, et al. Non-selective distribution of isomeric cholesterol hydroperoxides to microdomains in cell membranes and activation of matrix metalloproteinase activity in a model of dermal cells. Chem Phys Lipids 2013;174:17-23.
21. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med 2010;31:478-494.
22. Hollman PC, Cassidy A, Comte B, et al. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 2011;141:989s-1009s.
23. Sun SW, Zu XY, Tuo QH, et al. Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacol Sin 2010;31:1336-1342.
24. Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:98-105.
25. Fu C, He J, Li C, Shyy JY, Zhu Y. Cholesterol increases adhesion of monocytes to endothelium by moving adhesion molecules out of caveolae. Biochim Biophys Acta 2010;1801:702-710.
26. Tilghman RW, Hoover RL. The Src-cortactin pathway is required for clustering of E-selectin and ICAM-1 in endothelial cells. FASEB J 2002;16:1257-1259.
27. Voghel G, Thorin-Trescases N, Farhat N, et al. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech Ageing Dev 2007;128:662-671.
28. Farhat N, Thorin-Trescases N, Voghel G, et al. Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol 2008;86:761-769.
29. Trigatti BL, Anderson RG, Gerber GE. Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun 1999;255:34-39.
30. Marathe GK, Pandit C, Lakshmikanth CL, Chaithra VH, Jacob SP, D'Souza CJ. To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase. J Lipid Res 2014;55:1847-1854.
31. Kotosai M, Shimada S, Kanda M, et al. Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability. Lipids 2013;48:569-578.
32. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 2007;14:3209-3220.
33. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995;95:1262-1270.
34. White MC, Rastogi P, McHowat J. Lysoplasmenylcholine increases neutrophil adherence to human coronary artery endothelial cells. Am J Physiol Cell Physiol 2007;293:C1467-1471.
35. Mastick CC, Sanguinetti AR, Cao H, Thakker S. Phosphorylation of caveolin and signaling from caveolae. In: Fielding CJ, ed. Lipid Rafts and Caveolae: From Membrane Biophysics to Cell Biology, Germany: Wiley-VCH Verlag GmbH and Co., KGaA, 2006;116-140.
36. Colles SM, Chisolm GM. Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events. J Lipid Res 2000;41:1188-1198.
37. Golan DE, Brown CS, Cianci CM, Furlong ST, Caulfield JP. Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components. J Cell Biol 1986;103:819-828.
38. Takeshita S, Inoue N, Gao D, et al. Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. J Atheroscler Thromb 2000;7:238-246.
39. Kugiyama K, Sugiyama S, Ogata N, et al. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 1999;143:201-204.
40. Watanabe N, Zmijewski JW, Takabe W, et al. Activation of mitogenactivated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol 2006;168:1737-1748.
41. Volonte D, Zhang K, Lisanti MP, Galbiati F. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell 2002;13:2502-2517.
42. Dasari A, Bartholomew JN, Volonte D, Galbiati F. Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res 2006;66:10805-10814.
43. Shirai M, Yamanishi R, Moon JH, Murota K, Terao J. Effect of quercetin and its conjugated metabolite on the hydrogen peroxide-induced intracellular production of reactive oxygen species in mouse fibroblasts. Biosci Biotechnol Biochem 2002;66:1015-1021.
44. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-1144.
45. Scalia R, Murohara T, Campbell B, Kaji A, Lefer AM. Lysophosphat idylcholine stimulates leukocyte rolling and adherence in rat mesenteric microvasculature. Am J Physiol 1997;272(6 Pt 2):H2584-2590.
46. Sugiyama S, Kugiyama K, Ohgushi M, Fujimoto K, Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ Res 1994;74:565-575.
47. Kawai Y, Saito S, Nishikawa T, Ishisaka A, Murota K, Terao J. Different profiles of quercetin metabolites in rat plasma: comparison of two administration methods. Biosci Biotechnol Biochem 2009;73:517-523.
48. O'Leary KA, Day AJ, Needs PW, Sly WS, O'Brien NM, Williamson G. Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett 2001;503:103-106.
49. Koga T, Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 2001;73:941-948.
50. Li Y, Ying C, Zuo X, et al. Green tea polyphenols down-regulate caveolin-1 expression via ERK1/2 and p38MAPK in endothelial cells. J Nutr Biochem 2009;20:1021-1027.
51. Zheng Y, Lim EJ, Wang L, Smart EJ, Toborek M, Hennig B. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J Nutr Biochem 2009;20:202-209.
52. Moon JH, Nakata R, Oshima S, Inakuma T, Terao J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am J Physiol Regul Integr Comp Physiol 2000;279:R461-R467.
53. Egert S, Wolffram S, Bosy-Westphal A, et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008;138:1615-1621.
54. Tribolo S, Lodi F, Winterbone MS, et al. Human metabolic transformation of quercetin blocks its capacity to decrease endothelial nitric oxide synthase (eNOS) expression and endothelin-1 secretion by human endothelial cells. J Agric Food Chem 2013;61:8589-8596.
55. Dower JI, Geleijnse JM, Gijsbers L, Schalkwijk C, Kromhout D, Hollman PC. Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre) hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial. J Nutr 2015;145:1459-1463.